Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2049 - 2056 of 11616 results
What's Next?: California Court Strikes Down Board Diversity Law
April 14, 2022| News
OIG Approves Manufacturer’s Offer of Free Genetic Testing
April 14, 2022| Blog| Viewpoint
OCR RFI: Have You Implemented Your Recognized Security Practices?
April 13, 2022| Blog| Viewpoint
Top Ten Data Center Legal Issues – For Leases and MSAs
April 13, 2022| Video| Viewpoint
Cooley Life Sciences IP Team Departs to Mintz Boston Office
April 13, 2022| News
California Board Diversity Statute Unconstitutional
April 12, 2022| Alert| Viewpoint
Mintz Grabs IP Group From Cooley, Expanding Life Sciences Presence
April 12, 2022| News
New York City Commission on Human Rights Provides Salary Range Transparency Act Guidance
April 11, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.